David Hallett
Net worth: 4 M $ as of 2026-05-30
Net worth: 4 M $ as of 2026-05-30
David Hallett is Chief Scientific Officer at Recursion Pharmaceuticals, Inc. since 2024.
Formerly, Dr. Hallett was CEO, Executive Director & Chief Science Officer at Exscientia Ltd. in 2024 and EVP-Chemistry & Alliance Management at Evotec (UK) Ltd. from 2005 to 2019.
Education includes a doctorate from The University of Manchester and an undergraduate degree from the University of Cambridge.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-05-14 | 1,070,494 ( 0.2% ) | 4 M $ | 2026-05-30 |
| Companies | Position | Start |
|---|---|---|
| RECURSION PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 2024-11-19 |
| Companies | Position | End |
|---|---|---|
| EXSCIENTIA PLC | Chief Executive Officer | 2024-11-19 |
Evotec (UK) Ltd.
Evotec (UK) Ltd. Miscellaneous Commercial ServicesCommercial Services Provides research and development on natural sciences and engineering | Corporate Officer/Principal | 2019-11-30 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 5 |
|---|---|
Recursion Pharmaceuticals, Inc.
Recursion Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that combines biology, chemistry, automation, data science and engineering to industrialize drug discovery | Health Technology |
The University of Manchester
The University of Manchester Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Cambridge
University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Evotec (UK) Ltd.
Evotec (UK) Ltd. Miscellaneous Commercial ServicesCommercial Services Provides research and development on natural sciences and engineering | Commercial Services |
Exscientia Plc
Exscientia Plc Packaged SoftwareTechnology Services Function as an investment holding company whose subsidiaries provides artificial intelligence and machine learning services | Technology Services |
Select your edition
All financial news and data tailored to specific country editions